efficacy and safety of lenvatinib/everolimus in mrcc
Published 5 years ago • 172 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
2:37
lenvatinib/everolimus in refractory mrcc
-
5:32
lenvatinib and everolimus for advanced rcc
-
3:39
managing patients on lenvatinib/everolimus in mrcc
-
2:27
role for everolimus in mrcc treatment?
-
6:42
the role of lenvatinib in advanced rcc
-
6:22
mtor/tki combination therapy in kidney cancer
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
1:32
phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma
-
10:55
ikcs 2020: phase 2 trial of lenvatinib at 2 starting doses everolimus in renal cell carcinoma (rcc)
-
0:47
phase 2 trial shows antitumor activity in metastatic clear cell rcc
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
59:55
renal cell carcinoma: past, present, and future
-
1:40
comparing sorafenib and lenvatinib for the frontline treatment of advanced hcc
-
1:14
dr. larkin on lenvatinib plus everolimus in patients with rcc
-
4:15
case review: symptomatic metastatic renal cell cancer
-
0:57
dr. taylor discusses the toxicities and impact of lenvatinib in the select trial